Pfizer's vaccine for Clostridium difficile (C. diff) looks like it may join a growing list of candidates that have been shelved or delayed, after the shot failed to meet its primary objective in a ...

RBX2660 has been granted Orphan Drug status, Fast Track status and gained Breakthrough Therapy Designation from the FDA in October 2015 for its potential to prevent recurrent C. diff. infection.

Sixty-four more hospitals had a rate of zero, the lowest rate possible, for C. diff infections compared to CMS’ 2023 list.

It was an in-silico study that predicted the microbiome restorative potential of ibezapolstat for treating C. diff. Our scientific advisers consider this to be a major finding, which provides a ...

Hand sanitizer is great to have when you absolutely can't wash your hands, but you shouldn't depend on it, given its inability to kill certain bacteria or viruses such as C. diff and norovirus ...

Clinical trials to test vaccine against Alzheimer's-promoting tau protein Date: April 23, 2025 Source: University of New Mexico Health Sciences Center Summary: Researchers hope to launch human ...

Hand sanitizer is great to have when you absolutely can’t wash your hands, but you shouldn’t depend on it, given its inability to kill certain bacteria or viruses such as C. diff and norovirus ...

We recently published a list of Billionaire Ken Fisher’s 10 Healthcare Stock Picks with Massive Upside Potential.In this article, we are going to take a look at where Pfizer Inc. (NYSE:PFE ...

Diarrhea occurs when a person has loose or watery stools. Many different conditions have diarrhea as a symptom. Treatment may include taking medications, making dietary changes, and staying hydrated.

Pfizer Inc. reported its financial results for the first quarter of 2025, surpassing earnings expectations with an adjusted diluted earnings per share (EPS) of $0.92, compared to the forecasted $0 ...